TRV GP’s Rhythm Pharmaceuticals RYTM Stock Holding History

TRV GP’s Portfolio RYTM Stock Details RYTM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q4	–	Sell	-1,781,437	Closed	-$38.5M	–	3
2019 Q3	$38.5M	Sell	1,781,437 -200,000	-10%	-$4.29M	60.35%	1
2019 Q2	$43.6M	Hold	1,981,437	–	–	49.33%	1
2019 Q1	$54.3M	Sell	1,981,437 -1,000,000	-34%	-$28.7M	53.78%	1
2018 Q4	$80.1M	Hold	2,981,437	–	–	79.96%	1
2018 Q3	$87M	Sell	2,981,437 -1,000,000	-25%	-$31.6M	72.32%	1
2018 Q2	$124M	Hold	3,981,437	–	–	78.39%	1
2018 Q1	$79.2M	Hold	3,981,437	–	–	56.15%	1
2017 Q4	$116M	Buy	+3,981,437	New	+$105M	52.29%	1

Other funds holding RYTM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Janus Henderson Group

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Wellington Management Group

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return

BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return

MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return

Federated Hermes

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

Primecap Management

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return